NCT00870350View on ClinicalTrials.gov

An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster

PHASE4UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

June 30, 2010

Conditions
TetanusDiphtheriaPertussis
Interventions
BIOLOGICAL

Td5ap

Intramuscular injection of 0.5 mL Td5ap (COVAXiS) on day 1.

BIOLOGICAL

Td1aP

Intramuscular injection of 0.5 mL Td1aP (diTekiBooster) on day 1.

Trial Locations (1)

221 85

Swedish Institute for Infectious Disease Control, Lund

Sponsors

Collaborators (1)

MCM Vaccines B.V.
All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

collaborator

Statens Serum Institut

OTHER

lead

Swedish Institute for Infectious Disease Control

OTHER

NCT00870350 - An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster | Biotech Hunter | Biotech Hunter